Immunomedics Inc., of Morris Plains, N.J., was issued U.S. Patent No...Neurocrine Biosciences Inc., of San Diego, was issued U.S. Patent No...Vivus Inc., of Mountain View, Calif., was awarded U.S. Patent No

Advancis Pharmaceutical Corp., of Gaithersburg, Md., received U.S. Patent No...Akceli Inc., of Cambridge, Mass., was awarded U.S. Patent No...Entropin Inc., of Indio, Calif., was allowed U.S. Patent No

Diversa Corp., of San Diego, was granted U.S. Patent No...Lorus said the patent protects its intellectual property for its lead immunotherapeutic anticancer product, Virulizin, which is in a U.S.-based Phase III trial for pancreatic cancer...Provectus Pharmaceuticals Inc., of Knoxville, Tenn., received U.S. Patent No

OxiGene Inc., of Watertown, Mass., was awarded U.S. Patent No...Pacific Biometrics Inc., of Seattle, was granted U.S. Patent No...Targeted Genetics Corp., of Seattle, received U.S. Patent No

Cyntellect Inc., of San Diego, was awarded U.S. Patent No...Demegen Inc., of Pittsburgh, received U.S. Patent No...GenVec Inc., of Gaithersburg, Md., was issued U.S. Patent No

Advanced Biotherapy Inc., of Los Angeles, was issued U.S. Patent No...Amnis Corp., of Seattle, was issued U.S. Patent Nos...Chiron Corp., of Emeryville, Calif., was granted U.S. Patent No

BioCurex Inc., of Rancho Santa Margarita, Calif., was granted U.S. Patent No...CollaGenex Pharmaceuticals Inc., of Newtown, Pa., was granted U.S. Patent No...Esperion Therapeutics Inc., of Ann Arbor, Mich., was granted U.S. Patent No

Transkaryotic Therapies Inc., of Cambridge, Mass., was issued U.S. Patent No

Demegen Inc., of Pittsburgh, received U.S. Patent No...Egea Biosciences Inc., of San Diego, was granted U.S. Patent No...MethylGene Inc., of Montreal, received U.S. Patent 6,506,735 titled "Optimized Antisense Oligonucleotides Complementary to DNA Methyltransferase Sequences" covering optimized antisense oligonucleotides complementary to the DNA methyltransferase gene or its RNA transcript, including second-generation oligonucleotides, and methods for using such antisense oligonucleotides as

SuperGen Inc., of Dublin, Calif., was issued U.S. Patent No

Biolog Inc., of Hayward, Calif., received U.S. Patent No...Cyntellect Inc., of San Diego, received U.S. Patent No...Haemacure Corp., of Montreal, received U.S. Patent No

TissueInformatics Inc., of Pittsburgh, said it received from the U.S. Patent Office a notice of allowance covering tissue feature database construction...Specifically, the patent would cover a computer-implemented method of compiling and providing a database of structural, cell function or mechanical feature values for a defined set of tissue specimens

Royer Biomedical Inc., of Frederick, Md., was awarded U.S. Patent No...Celgene Corp., of Warren, N.J., received U.S. Patent No...Cima Labs Inc., of Minneapolis, was issued U.S. Patent No

D-Pharm Ltd., of Rehovot, Israel, was granted U.S. Patent No...DrugAbuse Sciences Inc., of Hayward, Calif., was awarded U.S. Patent No...Kaleidos Pharma Inc., of Seattle, was issued U.S. Patent No

Applied Genetic Technologies Corp., of Alachua, Fla., and the University of Florida in Gainesville, received U.S. Patent No...Ariad Pharmaceuticals Inc., of Cambridge, Mass., was issued a U.S...patent covering intramuscular administration of therapeutic genes controlled by its cell-signaling regulation technology - the product concept being used in Ariad's erythropoietin (EPO) anemia product candidate

Provectus Pharmaceuticals Inc., of Knoxville, Tenn., received U.S. Patent No...SuperGen Inc., of Dublin, Calif., was issued U.S. Patent No...Xeotron Corp., of Houston, was granted U.S. Patent No

Astex Technology Ltd., of Cambridge, UK, was issued U.S. Patent No...Astex also said it received from the U.S. Patent and Trademark Office a notice of allowance for a second antimicrobial drug target...Ganeden Biotech Inc., of Cleveland, received from the U.S. Patent and Trademark Office a notice of allowance protecting its topical antifungal product

Vion Pharmaceuticals Inc., of New Haven, Conn., received U.S. Patent No

PharmaStem Therapeutics Inc., of Wayne, Pa., was awarded U.S. Patent No...Vasogen Inc., of Toronto, received from the U.S. Patent and Trademark Office a notice of allowance for an application protecting the use of Vasogen's immune modulation therapy to treat chronic heart failure